What Will the Emerging Basal Insulin Products Mean for My Diabetes Practice?

Program Goals

Peglispro* vs Glargine: Effects on HbA1c in Pooled Analysis of Data From IMAGINE Trials 1-5

Peglispro* vs Glargine: Hypoglycemia Rates in Pooled Analysis Data From IMAGINE Trials 1-5

IDegLira* vs Glargine Comparison of Efficacy and Safety in DUAL V

LixiLan* vs Glargine No Increased Risk of Hypoglycemia at Any HbA1c Reduction Level

Post Hoc Analysis of EDITION 1 and 2 Effects of U300 vs Glargine on HbA1c

Clinical Implications for New and Emerging Long-Acting Insulins Which Patients May Benefit?

Abbreviations

References

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)